Form D · Biotechnology

Eterna Therapeutics Inc.

Cambridge, MA · CIK 0000748592

Offering snapshot reported Nov 14, 2024 · SEC filing

Reported sold
$3.89M
Offering amount: $3.89M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 24, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 14, 2024Initial$3,887,252No comparison11SEC filing
Nov 14, 2024Initial$1,137,746No comparison5SEC filing
Dec 20, 2023Initial$7,788,000No comparison19SEC filing
Jul 26, 2023Initial$8,715,000No comparison19SEC filing
Jul 26, 2023Initial$8,715,000No comparison19SEC filing
Dec 16, 2022Initial$7,712,874No comparison20SEC filing
Mar 23, 2022Initial$12,000,000No comparison1SEC filing
Nov 18, 2013Initial$2,400,000No comparison6SEC filing
May 26, 2009Initial$2,250,000No comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-529371

Source: Form D, filed Nov 14, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Matthew Angel Executive
Terry Bateman Director, Executive
Jeff Berg Director, Executive
Kendra Berger Executive
Brant Binder Director
James Bristol Director
Barry Chandler Executive
Charles Cherington Director
Peter Cicala Director
Dorothy Clarke Director, Executive
Kevin D'amour Executive
Erin S. Enright Director
Joseph J. Farricielli, Jr. Director
Howard J. Federoff Director, Executive
Gregory Fiore Director
Sandra Gurrola Executive
Andrew Jackson Executive
Kenneth L. Keymer Director
Vladimir Khuchua Edelman Executive
Dennis Langer Director
Mary Beth Lewis Director
Sanjeev Luther Director, Executive
Steve Mitgang Director
Erich Mohr Director
Kirk Nagamine Executive
Heather B. Redman Director
Jay Sial Executive
Roger Sidhu Executive
Nicholas J. Singer Director
Tony Uphoff Director
Richard W. Wagner Director
William Wexler Director
Paul Yanover Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1035 Cambridge Street Suite 18 A
Cambridge, MA, 02141